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ABSTRACT
MicroRNAs (miRNAs) have been widely studied in order to elucidate their biological functions. MicroRNA microarrays or miRNA
overexpression libraries generated by synthesis and cloning of individual miRNAs have been used to study their different roles. In
this work, we have developed a novel methodology to express mature miRNAs and other small RNAs from a double convergent
RNA polymerase III promoter. We show that the generated miRNAs function similarly to those processed from primary transcripts
or pri-miRNAs. This system allowed us to produce a lentiviral library expressing the whole population of small RNAs present in a
metastatic cell line. A functional screening using this library led to the identification of hsa-miR-30b and hsa-miR-30c as negative
regulators of cell death induced by loss of attachment (anoikis). Importantly, we demonstrated that the acquisition of anoikis
resistance via these miRNAs is achieved through down-regulation of caspase 3 expression. Moreover, overexpression of these
miRNAs resulted in a decrease of other types of caspase 3-dependent cell death and enhanced the survival of MCF10A acinar
cells in morphogenesis assays, suggesting a putative role as oncomirs. In summary, this novel methodology provides a powerful
and effective way for identifying novel small RNAs involved in a particular biological process.
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INTRODUCTION
It is estimated that ∼98% of the transcriptional output of
the human genome represents RNA that does not encode
proteins. Therefore, these noncoding RNAs (ncRNAs) are ei-
ther largely useless transcripts or they fulfill awide rangeof un-
expected functions in eukaryotic biology (Taft et al. 2010).
More specifically, microRNAs (miRNAs), the most studied
ncRNAs, regulate the expressionof hundredsof genes through
sequence-specific binding to mRNA (Bartel 2009; Kim et al.
2009). MicroRNAs are transcribed by RNA polymerase II
or III, which produce a primary transcript containing thema-
ture miRNA sequence and a varying amount of flanking re-
gions. For most mammalian miRNAs, the pri-miRNA folds
into a hairpin structure characteristic of miRNA genes.
Subsequently, a complex formed by the RNase III enzyme
Drosha and its cofactor Dgcr8 recognizes the hairpin and
cleaves the primary miRNA into a precursor miRNA, which
is exported from the nucleus by Exportin-5. After reaching
the cytoplasm, the precursor miRNA is further processed by
Dicer nuclease and loaded into the RNA-induced silencing
complex (RISC). Next, a specific single strand of the miRNA
duplex in the RISC is selected as a guide to direct sequence-
specific targeting ofmRNAs, usually through their 3′ untrans-
lated regions (UTRs), leading to translational repression and/
ormRNAs destabilization (Kim et al. 2009).MicroRNA target
genes can regulate several biological processes such as cell
development, differentiation, cell cycle and apoptosis (Inui
et al. 2010).Detachment of normal epithelial cells fromthe ex-
tracellular matrix triggers a type of programmed cell death
called anoikis. Anoikis is physiologically relevant during
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development, tissue homeostasis, and disease progression
(Chiarugi andGiannoni 2008). SeveralmiRNAs have been re-
ported to play a crucial role in tumorigenesis by regulating cell
proliferation and apoptosis as oncogenes (also called onco-
mirs) or as tumor suppressors (Bueno et al. 2008). Recently,
some of thesemiRNAshave been specifically involved in anoi-
kis, such as miR-214, miR-200c, or miR-221 (Gramantieri
et al. 2009;Howe et al. 2011; Penna et al. 2011).MiR-200c pro-
motes anoikis, butmiR-214 andmiR-221 inhibit it inmelano-
ma and in hepatocellular carcinoma-derived cell lines,
respectively.
Approaches to identify miRNAs involved in a particular bi-
ological process have been largely based on miRNA microar-
ray analysis or on the use of miRNA expression libraries.
Currently, these libraries are generated by cloning of individ-
ual miRNAs reported in different databases. In the present
work, we have developed amethodology to generate a lentivi-
ral library expressing the whole population of 19- to 29- nt
RNAs (including miRNAs and other RNAs, such as small nu-
cleolar RNAs, small nuclear RNAs, or small ribosomic RNAs)
present in the metastatic breast cancer and anoikis-resistant
cell line MDA-MB-231 (Fukazawa et al. 2004). We demon-
strate that the processed miRNAs expressed by dual conver-
gent promoters used in this library are functionally similar
to full-length expressed miRNAs and operate independently
of the components involved in miRNA biogenesis. A func-
tional screening using this library uncovered hsa-miR-30b
(miR-30b) and hsa-miR-30c (miR-30c) as inhibitors of anoi-
kis. These miRNAs promoted survival of the immortalized
retinal pigment epithelial cell line hTERT RPE1 (RPE-1)
growing under anoikis-inducing conditions by suppressing
Casp3 translation. Furthermore, miR-30b and miR-30c also
restrainedother types of caspase 3-dependent cell deathmech-
anisms as demonstrated by a delay in propermammary acinar
morphogenesis, an important event in the progression of ep-
ithelial tumors.
RESULTS
Design and validation of the processed miRNAs
expression system
Thedesignof the smallRNA(sRNA) librarieswasbasedon the
transcription of both strands of a shortDNA fragment flanked
by two human RNA polymerase III promoters, generating a
duplex RNAmolecule (Zheng et al. 2004). The lentiviral vec-
tor pLENT-DUAL contains twoRNApolymerase III termina-
tors just downstream from the transcriptional start sites of H1
andU6 promoters (Fig. 1A; Supplemental Fig. S1). After tran-
scription, the resulting smallRNAhas a similar structure as the
“natural” double-stranded processedmiRNA. DNA sequenc-
es corresponding to miR-21 (Lent-21), miR-19a (Lent-19),
and miR-15a (Lent-15) mature miRNAs were cloned into
the pLENT-DUAL vector to validate our technology. RNase
protection assays in HEK-293T cells demonstrated that the
guide strand of the double-stranded miRNA was stably over-
expressed. None, or very low signal, was detected for the com-
plementary strand (Fig. 1B; Supplemental Fig. S2A). In the
case of miR-21, similar expression profiles were observed be-
tween the expression of miR-21 transcribed from pLENT-
DUAL or from pCMV-21 full-length expressing the complete
pri-miR-21 (Fig. 1B, upper panel), although shorter isomirs
were detectedwhen thematuremiRNAwas directly expressed
(Berezikov 2011). The ability of the pLENT-DUAL system to
suppress gene expression was examined by analyzing the act-
ivityof the luciferase gene containing specificmiRNA-binding
sites for miR-21, miR-15a, or miR-19a in its 3′ UTR in HEK-
293T cells. A depletion of 35%–50% of luciferase activity
could be observed for both the processed and full-length ver-
sions of miR-21 (Fig. 1C, upper panel). Although the most
abundant mature miR-21 expressed from pLENT-DUAL
was 2 nt shorter than that expressed froma full-length version,
luciferase activity assays demonstrated that the level of expres-
sion of mature miR-21 with the expected length and/or the
shorter isomirs depleted a target efficiently. The reduced lucif-
erase activity was also observed in similar experiments using
pLENT-DUAL-19 or -15 plasmids (Fig. 1C, lower panel). In
addition, real time PCR experiments showed that the loss of
luciferase activity using pLENT-DUAL-21, -15, or -19 was
the result of a translational inhibition similar to that of the
pCMV-21 full-length construct (Supplemental Fig. S2B).
Furthermore, the processed miRNA-21 expressed from the
pLENT-DUAL system down-regulated the expression of the
luciferase open reading frame (ORF) fused to the complete
3′ UTR of the Pdcd4 gene, a well-known target of this
miRNA (Fig. 1D; Asangani et al. 2008). Next, we checked
whether the pLENT-DUAL expression system was indepen-
dent of the miRNA-processing pathway. In order to ensure a
potent reduction of the production of mature miRNAs from
pri-miRNAs, we needed to abolish both the cytoplasmatic
and nuclear processing steps. To this purpose, Dicer-deficient
HCT116 cells (Cummins et al. 2006) were infected with a len-
tivirus carrying a small hairpin RNA against DGCR8 mRNA
(Kumar et al. 2007), which encodes a RNA-binding protein
required for pri-miRNA biogenesis. In these cells, miR-21 ex-
pressed from the pCMV-21 full-length plasmid failed to
deplete luciferase expression, whereas the processed miR-21
expressed frompLENT-DUALmaintained the level of repres-
sion (Fig. 1E). This indicates that our miRNA expression sys-
tem seems to be independent of the miRNA processing
machinery. Taken together, our data demonstrate the general
and versatile applicability of pLENT-DUAL to drive function-
al miRNA (and other types of small RNA functioning as
miRNA or siRNA) expression experiments.
Generation of a lentiviral small RNA-expressing library
and its use in a functional screening
MDA-MB-231 (clone 4175) human breast cancer cells were
selected to generate a library of small RNAs because of their
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high invasive ability and metastatic potential. Small 19- to
29-nt RNAs from this anoikis-resistant cell line were isolated
by polyacrylamide gel electrophoresis and subjected to
sequential modifications including 3′- and 5′-adapter liga-
tion, RT-PCR amplification, and direc-
tional cloning into the pLENT-DUAL
plasmid (Fig. 2A; Supplemental Fig. S1).
Escherichia coli cells were electroporated
andmore than 8 × 105 independent colo-
nies were pooled to compose the library.
In order to check the complexity and
quality of the library, we carried out a
deep-sequencing analysis of the small
RNAs cloned into the pLENT-DUAL vec-
tor as well as the small RNA population
from MDA-MD-231 cells (Fig. 2B,C;
Supplemental Table S1). We found that
not only miRNAs were present in our li-
brary but also other small noncoding
RNAs, such as snoRNAs, tRNA-derived
small RNAs, small RNAs from coding
and noncoding regions, rRNA, small
RNAs from repeat regions, and other
types of sRNAs (Fig. 2B). In addition,
the comparison betweenmiRNAs present
in the small RNA population of MDA-
MB-231 cells and miRNAs from small
RNAs cloned into pLENT-DUAL showed
a high level of correlation (R2 = 0.652)
even though it was difficult to compare li-
braries generated by different protocols
(Fig. 2C; Supplemental Table 1; Hafner
et al. 2011; Toedling et al. 2012; Zhuang
et al. 2012). Notably, ∼71% of miRNAs
with more than five reads per million
(rpm) in theMDA-MB-231 small RNA li-
brary were present at five or more rpm in
the pLENT-DUAL library. Additionally,
the pLENT-DUAL library contained a
moderately high percentage (62%) of iso-
mirs present inMDA-MB-231, indicating
that the library was free of major se-
quence/size biases. These results demon-
strated that our library contained most
of the miRNAs highly or moderately ex-
pressed in MDA-MB-231 and showed a
high degree of complexity, including oth-
er types of small RNAs, some of them be-
ing able to function as miRNAs.
To perform a functional screen for
anoikis suppression, we used nonmalig-
nant, anoikis-sensitive RPE-1 cells (Sup-
plemental Fig. S3; Alfano et al. 2006).
These cells were infected with the lentivi-
ral library (MOI = 1) or empty pLENT-
DUAL lentiviruses as a control for 72 h, transferred to
agar-covered Petri dishes, and kept in culture for 19 d at low
confluence to avoid any contact (Fig. 3A; see Materials and
Methods section for details). Seventeen clones from cells
FIGURE 1. MaturemiRNAs expressed under the control of dual convergent promoters are func-
tionally similar to full-length expressed miRNAs. (A) Schematic drawing showing the plasmid
used to express mature miRNAs and others small RNAs. (B) RNase protection assay of miR-
21, miR-19a transiently overexpressed from the pLENT-DUAL plasmid in HEK-293T cells (upper
and lower panel). miR-21 full-length (miR-21 FL) was expressed from a pCMV-miR-21 plasmid.
Control (Ctr) cells expressed the empty vectors pLENT-DUAL or pCMV. Y corresponds to yeast
RNA. (C) Transient transfections were carried out in HEK-293T cells, using pLENT-DUAL-21,
-19, -15 (expressing the mature form of miR-21, miR-19a or miR-15a, respectively) or pCMV-
miR-21 full-length, pLuc-BS carrying a binding site for miR-21, miR-19a or miR-15a
and pCMV-Renilla (normalization control) at 100:10:1 proportions, respectively. Firefly and
Renilla activities were measured 40 h after transfection. (D) Similar luciferase assay as described
in C, using pLENT-DUAL-miR-21 and pCMV-miR-21 full-length and a plasmid harboring a
652- nt wild-type sequence corresponding to the 3′ UTR of PDCD4 at the 3′ position of the lu-
ciferase reporter gene. (E) Similar luciferase assay as described in C in HCT116 DICER −/− cells,
using pLENT-DUAL-miR-21 and pCMV-miR-21 full-length and a plasmid carrying a binding
site for miR-21. For these experiments, HCT116 DICER −/− cells infected with a lentivirus ex-
pressing a small hairpin RNA againstDGCR8were used. All transfections were performed in trip-
licate, and results are shown as the averages ± standard errors of the means from at least three
independent experiments. The data were subjected to two-tailed Student’s t-test [(∗) P < 0.05,
(∗∗∗) P < 0.001], with the exception of section E, where a two-way ANOVA followed by
Bonferroni’s post-test was used. (∗) P < 0.05.
Small RNA libraries for functional screens
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infected with the lentiviral library containing at least 50 cells
were isolated and transferred to adhesive culture dishes to al-
low the expansion of anoikis-resistant colonies. Only one
clone was isolated from cells infected with empty pLENT-
DUAL lentivirus, which was unable to proliferate in an adhe-
sive culture dish. In order to knowwhich sRNAswere respon-
sible for the observed anoikis-resistant phenotype, lentiviral
DNA from independent clones was amplified and sequenced
(Fig. 3B). Notably, although in these long-term anoikis assays,
cells overexpressing the selected small RNAs formed colonies
in soft agar, miR-30b- and miR-30c (miR-30b/c)-overex-
pressing clones seemed to proliferate much more rapidly
(data not shown).
Additionally, RPE-1 cells were infected with empty
pLENT-DUAL or pLENT-DUAL carrying individual mature
miRNA candidates and the number of apoptotic cells mea-
sured in a short-term anoikis experiment (Supplemental
Fig. S3). Among all the candidates, only miR-30b/c-express-
ing clones achieved a solid and significant anoikis-resistant
phenotype, showing a 40%–45% reduction in the number
of cells with a subG1 DNA content, compared to control cells
(Fig. 3C). Thus,miR-30b/c induced anoikis resistance in both
short- and long-term experiments, and they were selected
for a detailed study. Interestingly,miR-30c and,more notably,
miR-30b, were present in the pLENT-DUAL library at a low
percentage (0.187% and 0.0173%, re-
spectively) (Supplemental Table S1),
meaning that low-abundant small RNAs
can be isolated and identified in awell-de-
signed functional screening using our
novel libraries. RNase protection assays
demonstrated that the guide strands
of the double-stranded miR-30b and
miR-30c were stably overexpressed from
pLENT-DUAL plasmids. None or very
low nonspecific signal was detected for
the complementary strands (Fig. 3D).
Similar results were observed when
RPE-1 cells were infected with lentivirus-
es overexpressing full-length miR-30b/c
(Fig. 3E; Supplemental Fig. S4A). There-
fore, the identification of miR-30b/c as
regulators of anoikis validated our novel
small RNA expression library and its ap-
plication for functional screenings.
Caspase 3 is the main target of miR-
30b/c for anoikis regulation
Anoikis is a very complex process that in-
volves signalling at various levels (Chiar-
ugi and Giannoni 2008). In order to
identify putative targets of miR-30b/c,
different computational algorithms in-
cluding those applied in software such
as miRanda (Betel et al. 2008), TargetScan (Friedman et al.
2009) and DIANA-microT (Maragkakis et al. 2009) were
used. We found several genes related to the induction of cell
death containing at least one putative miR-30b/c binding
site in their 3′ UTR predicted by all three resources. Among
these genes, we selected BCL2-like 11 (BIM), TP53 (p53),
and caspase 3 (CASP3) because they had already been shown
to be involved in the anoikis process (Chiarugi and Giannoni
2008). As shown in Figure 4A,Western blot experiments con-
firmed that among these three candidates, only caspase 3 ex-
pression was depleted by miR-30b/c. In cells growing under
adherent conditions and overexpressing miR-30b/c, the ex-
pression levels of pro-CASP3 were reduced to 25%–40% of
the levels in control cells infected with a lentivirus carrying
an empty vector. Notably, active CASP3 protein levels in non-
adherent conditionsweremeasured in these cells, and a signif-
icant reduction (25%–50%) was observed in miR-30b/c-
overexpressing cells (Fig. 4A,B). Furthermore, quantitative
PCR analysis determined that CASP3mRNA levels remained
constant in both control andmiR-30b/c-expressing cells, sug-
gesting that depletion of the protein was caused by transla-
tional inhibition (Supplemental Fig. S5).
Using the TargetScan software (Friedman et al. 2009), two
putative binding sites for miR-30b/c located in the 3′ UTR of
caspase 3 were found. One of them was highly conserved
FIGURE 2. Generation of a small RNA library from MDA-MB-231 (clone 4175) cells. (A)
Scheme illustrating the small RNA cloning strategy to generate expression libraries based on
the pLENT-DUAL lentiviral vector. (B) Pie chart representing the percentage of the different clas-
ses of small RNAs in the pLENT-DUAL library. (Repeats) Regions annotated as repeats (of any
type, excluding simple repeats and primarily transposable elements), (scRNA) small cytoplasmic
RNA, (other hairpins) loci that look like hairpins but do not pass all the criteria for annotation as
miRNAs, (sense strand) small RNAmatching sense strand to coding and noncoding regions, (an-
tisense strand) small RNA matching antisense strand to coding and noncoding regions. (C) A
correlation between known miRNAs expressed in MDA-MB-231 cells and known miRNAs
cloned in the library (log [1 + number of reads normalized to total number of mapped reads]).
R2 derived from Pearson’s correlation of the data is indicated.
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among different mammalian species, while the other showed
low conservation. To verify the functionality of these sites,
the 3′ UTR of CASP3 was cloned into a reporter vector,
and luciferase assays, using the wild-type sequence (WT)
and sequences mutated in the highly (Mut1) or poorly
(Mut2) conserved sites, were carried out (Fig. 4C). Cells
were transfected with the control or miR-30b/c plasmid
and the different versions of the 3′ UTR of CASP3. Figure
4C shows that miR-30b and miR-30c decreased luciferase ac-
tivity only when the highly conserved site was intact, showing
FIGURE 3. A functional screening using a novel small RNAs expression library reveals hsa-miR-30b and hsa-miR-30c as repressors of anoikis. (A)
Immortalized RPE-1 cells were infected with a lentiviral expression library containing a small RNAs collection from the MDA-MB-231 cell line.
RPE-1-infected cells were cultured for 19 d in agar dishes at low confluence avoiding any contact and surviving clones transferred to adhesive culture
dishes to allow the growth of anoikis-resistant cells. DNA from these clones was isolated and sequenced. (B) Table showing the small RNA sequences
overexpressed in anoikis-resistant clones. (C) Flow cytometry analysis of the levels of apoptosis in RPE-1 cells (SubG1/SubG1 control + polyHEMA)
infectedwith lentivirus containing candidatematuremiRNAs or empty vector (control). Three days after infection, cellswere deprivedof serum for 24h
and then cultured in polyhema (PH) plates plus methylcellulose (2%) in serum-free medium for another 24 h. (D) RNase protection assay of miR-30b
andmiR-30c transiently overexpressed inHEK-293 cells frompLENT-DUAL plasmid. Control (Ctr) cells expressed the empty vector pLENT-DUAL; Y
corresponds to yeast RNA; M, Decade RNAmarkers (Ambion). (E) Levels of apoptosis in RPE-1 cells (SubG1/SubG1 control) infected with lentivirus
carrying full-length miR-30b, miR-30c-1 (FL), miR-30b/c mature miRNAs (Lent-30b/c), and the corresponding empty vectors as controls in a similar
assay as described inC. Results are shown as the averages ± standard errors of themeans from at least three independent experiments andwere analyzed
by one-way ANOVA, followed by Bonferroni post-test for significance versus control cells. (∗) P < 0.05, (∗∗) P < 0.01, (∗∗∗) P < 0.001.
Small RNA libraries for functional screens
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that the regulation of caspase 3 expression by miR-30b/c was
achieved directly through a conserved binding site in its 3′
UTR.
In addition, the expression of aCASP3mRNA lacking the 3′
UTR rescued CASP3 levels in RPE-1 cells overexpressing
miR-30b/c (Fig. 5A, upper panel). The reconstitution of
CASP3 protein levels led to a reversion of the anoikis-resistant
phenotype inmiR-30b/c-overexpressing RPE-1 cells (Fig. 5A,
lower panel). Moreover, the depletion of caspase 3 expression
by short hairpin RNA in RPE-1 cells was sufficient to mimic
or even improve the anoikis resistance described in cells over-
expressing miR-30b/c (Fig. 5B). Importantly, RPE-1 cells sta-
bly expressing shRNA targeting caspase 3 formed anchorage-
independent colonies (Fig. 5C), pointing out caspase 3 as the
key target for the control of cell detachment-induced apopto-
sis by these miRNAs.
Other members of miR-30 family do not confer anoikis
resistance in RPE-1 cells
Wehave shown that allmembers ofmiR-30 family are present
in our library (Supplemental Table S1) and presumably share
most of the targets because they contain the same seed se-
quence at the 5′ end of their mature sequence. Based on this
fact, we investigated if other miRNAs belonging to miR-30
family were able to deplete caspase 3 expression and repro-
duce the phenotype observed following miR-30b/c over-
expression. As RNase protection assays showed, miR-30a
and miR-30d were expressed properly in cells transfected
with pLENT-DUAL-30a and pLENT-DUAL-30d plasmids
(Supplemental Fig. S6). Using previously described lentiviral
systems (Gaziel-Sovran et al. 2011; Baraniskin et al. 2012),
miR-30a and miR-30d were overexpressed in RPE-1 cells
(Supplemental Fig. S7), and pro-CASP3 depletion was
checked by Western blot (Fig. 6A). Enforced expression of
miR-30d depleted pro-CASP3 levels, but this effect was not
able to attenuate apoptosis induced by lack of cell adhesion
(Fig. 6B). Interestingly, the levels of pro-CASP3 were not af-
fected by miR-30a overexpression but significantly increased
anoikis in RPE-1 cells (Fig. 6A,B). Furthermore, luciferase as-
says using the described reporter vector (Fig. 4C) showed that
overexpression of miR-30a did not deplete luciferase expres-
sion (data not shown). Notably,miR-30b, but notmiR-30a/c/
d, was expressed at significantly higher levels in MDA-
MB-231 cells in comparison to RPE-1 cells (Fig. 6C), indicat-
ing that at least one of the miR-30 family members identified
in the screening is up-regulated in this anoikis-resistant
cell line.
miR-30b/c negatively modulate other CASP3-dependent
biological processes
CASP3 is an executioner Caspase involved in the last stage of
the apoptotic-signalling pathway (Strasser et al. 2011).
Therefore, depletion of CASP3 mediated by miR-30b/c
FIGURE 4. Hsa-miR-30b and hsa-miR-30c down-regulate CASP3 ex-
pression through its 3′ UTR-binding. (A) Western blot analysis of p53,
CASP3, and BCL2-like 11 (BIM), three putative target proteins of miR-
30b/c related to anoikis. RPE-1 cells were infected with lentivirus ex-
pressing full-length miR-30b, miR-30c-1 (miR-30c), or empty vector
as a control. Active CASP3 was analyzed in cells cultured under anoikis
conditions as described in Figure 3C. Actin (ACTB) was used as the
loading control. (B) Densitometric analysis of pro-CASP3 and active
CASP3 levels. ACTB protein was used as the normalization control.
Results are shown as the averages ± standard errors of the means from
at least three independent experiments and were analyzed by one-way
ANOVA, followed by Bonferroni post-test (∗P < 0.05; ∗∗P < 0.01). (C)
Schematic representation of the caspase 3 3′ UTR containing two puta-
tive binding sites for miR-30b/c. The 3′ UTR of CASP3 mRNA was
cloned downstream from the open reading frame of luciferase (pLuc-
BS). Both broadly (1187–1193) and poorly (1222–1228) conserved pu-
tative miRNA regulatory elements of the CASP3 3′ UTR were mutated
(Mut1 and Mut2, respectively) and cloned along with the wild-type 3′
UTR (WT). HEK-293T cells were transiently cotransfected with plas-
mids overexpressing full-length miRNAs (miR-30b, miR-30c-1, or
empty vector as control), pLuc-3′ UTR CASP3 (WT, Mut1, or Mut2)
and pCMV-Renilla at 100:10:1 proportions, respectively. Firefly and
Renilla activities were measured 40 h after transfection. The luciferase
activity normalized to Renilla is shown (lower panel). Transfections
were performed in triplicate, and results are shown as the averages ±
standard errors of the means from at least three independent experi-
ments and were analyzed by one-way and two-way ANOVA, followed
by Bonferroni post-test. (∗) P < 0.05, (∗∗) P < 0.01, (∗∗∗) P < 0.001,
(ns) not significant.
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overexpression could affect diverse apoptotic mechanisms ac-
tivated by other stimuli beyond the lack of cell adhesion. To
this purpose, we studied CASP3-dependent apoptosis medi-
ated by TNF-related apoptosis-inducing ligand (TRAIL) in
the immortalized human mammary epithelial cell line
MCF-10A. As we have previously described for anoikis, over-
expression of miR-30b/c in MCF-10A cells (Supplemental
Fig. S4B) led to a reduction of 35%–50% in TRAIL-mediated
apoptosis compared to control cells (Fig. 7A). Importantly, a
correlation between the reduction of apoptotic cells and the
depletion of CASP3 protein level in cells overexpressing
miR-30b/c could be observed (Fig. 7B), suggesting a direct
link between the overexpression of these miRNAs and cell
death resistance following down-regulation of CASP3. In or-
der to investigate the physiological role ofmiR-30b/c in tumor
formation, we carried out amorphogenesis assay usingMCF-
10A cells. These cells, when plated on a bed of extracellular
matrix, undergo morphogenesis characterized by a prolifera-
tive phase and an apoptotic phase resulting in formation of
proliferation-arrested 3D structures made up of polarized ep-
ithelial cells surrounding a central hollow lumen (Debnath
and Brugge 2005). Interestingly, lumen formation appears
to be driven by the removal of cells that have been detached
from the extracellular matrix, rendering them susceptible to
anoikis and other caspase-independent cell death mecha-
nisms. To determine whethermiR-30b/c interferes withmor-
phogenesis of 3D acini, MCF10A overexpressing miR-30b/c
andMCF10A control cells were seeded inMatrigel. As report-
ed (Debnath and Brugge 2005), we observed virtually no ap-
optosis in the developing acini until day 5. Thereafter, as the
structure grew, a delay on hollow lumen formation in acini
overexpressing miR-30b/c was observed (Fig. 7C, left panel).
This delay was associated with a decreased apoptotic rate in
these acini in comparison with control acini. In fact, after
day 12, control acini contained an increased amount of apo-
ptotic cells, as was determined by immunofluorescence of
cleaved CASP3. In contrast to this pattern, very low immuno-
fluorescence signal of cleaved CASP3 was detected in mir-
30b/c-overexpressing acini. After day 18, a significant per-
centage of the control acini were hollow, whereas in miR-
30b/c-overexpressing acini, the luminal space was densely
populatedwith apoptotic cells (Fig. 7C, right panel). These re-
sults revealed that miR-30b/c overexpression during mam-
mary acini development in 3D results in a deregulation of
the process, leading to a delay of acini clearance associated
with a decrease of CASP3 activation.
DISCUSSION
In this work, we have developed a novel system for the direct
expression of mature miRNAs. Using different approaches,
we have demonstrated that these mature miRNAs have a
comparable length and function similar to processed full-
length miRNAs expressed from RNA polymerase II or
endogenous promoters, although some particular isomir var-
iants (Fig. 1B, upper panel; Berezikov 2011) and differences
in the efficiency of gene down-regulation were found (Fig.
1E). Our system has enabled the generation of a novel type
of lentiviral expression library containing a significant repre-
sentation of the population of mature miRNAs from a
FIGURE 5. Caspase 3 is the main target of miR-30b/c in the anoikis-re-
sistance context. (A) RPE-1 cells were co-infected with both lentiviruses
expressing full-length miR-30b/c and the ORF of caspase 3. Western
blot analysis of pro-CASP3, active CASP3, and ACTB is shown for
RPE-1 cells growing either in complete medium under adherent condi-
tions (−PH) or in anoikis-inducing conditions (+PH). Flow cytometry
analysis of the levels of apoptosis (SubG1/SubG1 control) in CASP3-in-
fected cells growing under anoikis-inducing conditions (lower panel).
(B) RPE-1 cells were infected with either lentivirus expressing a
shRNA to silence the expression of caspase 3 or a scramble shRNA (con-
trol). Experiments were carried out with RPE-1 infected cells previously
selected in puromycin for 12 d. The diagram to the left shows CASP3
mRNA levels measured by real time PCR after puromycin selection.
HPRTmRNAwas used as the normalization control. On the right, levels
of apoptotic cells in anoikis-inducing conditions are shown. Results are
shown as the averages ± standard errors of the means from three inde-
pendent experiments. The data were subjected to two-tailed Student’s
t-test. (∗∗) P < 0.01, (∗∗∗) P < 0.001. (C) Number of colonies after plat-
ing 2 × 104 cells from B per well in six-well plates with a bottom layer of
0.5% agar and a top layer of 0.35% agarose. Colonies were photographed
and counted after 4 wk. Results are shown as the averages ± standard er-
rors of the means from three independent experiments. The data were
subjected to two-tailed Student’s t-test. (∗∗) P < 0.01.
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particular cell line as well as other types of small RNAs that
can function as miRNAs. At present, other miRNA expres-
sion libraries have been developed to carry out gain-of-
function genetic screens in different formats such as dou-
ble-stranded miRNA or expressing full-length pri-miRNA
in a plasmid or a viral-based vector (Izumiya et al. 2011).
Lentiviral libraries have overcome the problems derived
from double-stranded miRNAs and plasmid libraries, such
as efficiency of transfection and transient expression.
However, all these strategies have shown limitations due to
the high cost and/or technical difficulties. Moreover, the con-
tent of these libraries is limited to miRNAs annotated in the
different databases. In our libraries, the small RNAs have
been cloned and tested to identify those RNAmolecules lead-
ing to a particular phenotype, avoiding tedious steps such as
identification of putative miRNAs and
the subsequent isolation and cloning of
DNA precursors sequences.
pLENT-DUAL lentiviral particles are
produced in a lower rate (about 10-fold
less) than other conventional lentivi-
ruses (see Materials and Methods for de-
tails). In order to get a higher yield and to
guard against possible artefacts, the se-
lected candidates in the functional screen
were generated and tested as pre-miRNAs
in a canonical vector. Despite this, the
libraries reported here provide several
significant improvements. They include
known and novel small RNAs, which
can be stably expressed as double-strand-
ed RNA. As was expected, highly or
moderately expressed miRNAs in MDA-
MB-231 cells were found in a higher
proportion in the pLENT-DUAL library.
Remarkably, deep-sequencing analysis
to test the quality of the library revealed
that not onlymiRNAs but also other types
of small RNAs, such as small nuclear
RNAs, small nucleolar RNAs, and small
RNA derived from tRNAs, were repre-
sented in the library (Fig. 2B; Supple-
mental Table 1). Some of these small
RNAs interact with the RISC complex
and have been described as “miRNA-
like” RNAs capable of regulating gene ex-
pression (Berezikov 2011; Rother and
Meister 2011; Dueck et al. 2012; Li et al.
2012b). Therefore, this novel approach
progresses toward the generation of small
RNA (especially those functioning like a
siRNA or miRNA) expression libraries,
and its use constitutes a valuable resource
tool for gene analysis and discovery in
mammalian systems. Of great interest is
the application of this technology for functional screenings
in cell types from less well- or noncharacterized organisms
with poor small RNA sequencing data. The fact that a signifi-
cant amount of miRNAs are expressed at saturating levels
and/or can function redundantly in a wild-type background
often complicates the study of individual miRNAs function
(Wang et al. 2008). Using this novel technology, we have dem-
onstrated that the expression of miRNAs from the pLENT-
DUAL system is independent of the biogenesis of primary
and precursor forms that precedes the generation of the ma-
ture miRNA, enabling the performance of long-term func-
tional screens in different genetic backgrounds where
mature endogenous miRNAs (or other small RNAs) are not
being produced. Moreover, the protocol to generate the li-
brary could be adaptable to short synthetic oligonucleotides,
FIGURE 6. Hsa-miR-30a and -30d do not confer anoikis resistance in RPE-1 cells. (A) Western
blot analysis of pro-CASP3 in RPE-1 cells infected with lentivirus expressing full-length miR-30a,
miR-30d, or their corresponding empty vectors as control. Actin (ACTB) was used as the loading
control. On the right, densitometric analysis of pro-CASP3 is shown. ACTB protein was used as a
normalization control. (B) Flow cytometry analysis of the levels of apoptosis (SubG1/SubG1 con-
trol) in infected cells growing under anoikis-inducing conditions. (C) Endogenous levels of ma-
ture miR-30a/d (left panel) and miR-30b/c (right panel) expressed in RPE-1 and MDA-MB-231
(clone 4175) cells. miR-16 and miR-324 were used as normalization controls for miR-30b/c and
miR-30a/d, respectively. Similar results were observed when human U6 snRNA primer and U6-
snRNA (RNU6B) were used as controls. Results are shown as the averages ± standard errors of the
means from three independent experiments. The data were subjected to two-tailed Student’s
t-test. (∗) P < 0.05.
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allowing the generation of a library at
much lower cost than when producing
the long oligonucleotides required for
classical microRNA or shRNA hairpins.
In addition, once miRNAs are expressed,
they result in two different mature mole-
cules annotated as miRNA/miRNA∗ or
miRNA-5p/miRNA-3p. An extra advan-
tage of our libraries is to permit the specif-
ic and stable overexpression of one of the
miRNA species and not its natural associ-
ated molecule.
In order to validate our technology, a
functional screening was carried out in
the anoikis-sensitive cell line RPE-1 in-
fected with a lentiviral library comprising
a good representation of the population
of miRNAs and other small RNAs ex-
pressed in the cell line MDA-MB-231.
This screening enabled us to identify
hsa-miR-30b and hsa-miR-30c as novel
negative regulators of cell death induced
by loss of attachment even when these
miRNAs were present at low percentage
in our library. This supports the high
potential of our libraries to uncover
miRNAs and other “miRNA-like” small
RNAs. The phenotype described for the
mature miRNAs overexpressed using
our system was confirmed by expression
of the full-length miRNA versions, vali-
dating our previous data on the novel
small RNAs expression system and dem-
onstrating that the phenotype observed
was due to the function of the guide
strands ofmiR-30b/c and not to the com-
plementary or passenger strands. These
results areconsistentwithpreviously pub-
lished data that classify miR-30b and
miR-30c as oncomirs (Volinia et al.
2010; Garofalo et al. 2011). In addition,
a paper demonstrating a role of miR-
30b/c as oncomirs in glioma and lung
cancer cells has been recently published
(Quintavalle et al. 2013). In these tu-
mor-derived cells, miR-30b/c conferred
TRAIL-induced apoptosis resistance tar-
geting caspase 3 through the conserved
binding site in its 3′ UTR, similarly as we
have demonstrated for immortalized epi-
thelial cells. These recent and indepen-
dent results confirm and reinforce this
novel small RNA expression system as a
powerful technique for uncovering new
small RNAs (miRNAs, among others)
FIGURE 7. Hsa-miR-30b and hsa-miR-30c reduce cell death induced by TRAIL and delay acini
clearance in MCF10A cells. (A) Cells were infected with lentivirus containing full-length miR-
30b, miR-30c, and empty vector as a control. Four days after infection, cells were cultured in
the presence of Trail (500 ng/mL) for 7 h, and the levels of apoptosis were determined
(SubG1/SubG1 control + Trail) by flow cytometry. Values represent the average ± standard errors
of the mean from three independent experiments. The data were analyzed by one-way ANOVA,
followed by Bonferroni post-test. (∗∗) P < 0.01. (B) Western blot analysis of pro-CASP3 levels in
infected cells. ACTB was used as a loading control. On the right, a densitometric analysis of pro-
CASP-3 protein levels from three independent experiments is shown. ACTB was used as a nor-
malization control. Values represent the average ± standard errors of the mean from at least three
independent experiments. The data were analyzed by one-way ANOVA, followed by Bonferroni
post-test. (∗) P < 0.05, (∗∗) P < 0.01. (C) Effects of overexpression of miR-30b/c on MCF10 acini
morphogenesis assays. Cells were infected as in A and assayed for acinar clearance. For 24 d, acini
were fixed and analyzed by confocal microscopy every 6 d. Activation of CASP3 was determined
with an antibody specific to cleaved CASP3 (red). Acinar morphology was visualized using an α6-
integrin antibody (green), and 4′,6-diamidino-2-phenylindole was used to stain nuclei (blue).
Results are shown as the averages ± standard errors of the means from three independent exper-
iments, and 100 acini were analyzed in each condition. The data were analyzed by one-way
ANOVA, followed by Bonferroni post-test. (∗) P < 0.05, (∗∗) P < 0.01. Percentage of acini con-
taining four or less intact nuclei in lumen was measured at the indicated time points during mor-
phogenesis. On the right, representative images of acini on day 12 and 18 corresponding to control
or miR-30b/c-overexpressing cells. Scale bars, 75 μM.
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involved in a particular biological process. In addition, our re-
sults point out that not all members belonging to a particular
miRNA family are functionally similar, and they can even be
involved in antagonisticprocesses. In fact,no additionalmem-
bers of themiR-30 family sharing the seed sequencewere iden-
tified in this screening, although they were present in the
library. Despite the fact that miR-30d depleted pro-CASP3,
as has been recently proposed for cancer cells (Li et al.
2012a), this does not seem to be sufficient to block anoikis in
these immortalized cells. The supplementary pairing outside
of the seed region of miRNAs affects the target specificity, de-
creasing the dissociation rate of the bound silencing complex
(Brennecke et al. 2005; Grimson et al. 2007). Interestingly,
miR-30d and miR-30b/c differ significantly outside of the
seed region (nt 13,14, and 18–20). This fact could generate,
for each miRNA, specific targets involved in other apoptotic
or anti-apoptotic processes. Because under our experimental
conditions, anoikis seemed to be mainly reduced by only
down-regulationofCASP3 inRPE-1,miR-30doverexpression
might affect other unknown targets in this cell line that offset
the depletion of CASP3 levels. Notably, only one mismatch
at the 12th nucleotide was found between miR-30a and miR-
30d. This nucleotide may be important because, in cells over-
expressing miR-30a, neither a depletion of pro-CASP3 nor an
inhibition of cell death induced by lack of attachment was ob-
served. Inaddition, luciferaseassaysusing the3′UTRofCASP3
cloned into a reporter vector showed that overexpression of
miR-30a did not deplete luciferase expression (data not
shown). In contrast, a significant increase of the cell death
(Fig. 6B) as well as cell growth inhibition was clearly visible
inRPE-1cells overexpressingmiR-30a, suggesting that ectopic
expressionof thismiRNAwas functional and related to theob-
served tumor suppression. Consequently, miR-30a has been
described as a suppressor of tumor growth and inhibitor of
cell migration and invasion (Baraniskin et al. 2012; Cheng
et al. 2012; Kumarswamy et al. 2012; Zhang et al. 2013).
Altogether, our results indicate that miR-30b/c and not other
miR-30 familymembers are specifically involved in anoikis re-
sistance. Interestingly, mature miR-30b and miR-30c shared
the highest degree of identity beyond the seed sequencewithin
miR-30 familymembers, andmiR-30b/cwere expressedmore
abundantly in the metastatic MDA-MB-231 cell line than in
immortalized MCF-10A cells (Wang et al. 2009). MiR-30b,
andnotothermiR-30 familymembers,wasalsooverexpressed
in MDA-MB-231 cells compared to RPE-1. Although the de-
pletion of miR-30b/c did not affect the anoikis resistance in
MDA-MB-231 cells (data not shown), these miRNAs seem
to collaborate positively in tumor progression. Importantly,
miR-30a and miR-30d are more abundant than miR-30b
andmiR-30c in thegenerated library fromMDA-MB-231 cells
(miR-30a = 0.416%;miR-30d = 0.19%;miR-30b = 0.0173%;
miR-30c = 0.187%), but only miR-30b and miR-30c were se-
lected in the functional screening. This reinforces the idea that
the library represents a bona fide technology for functional
screenings, making possible the isolation of specific members
belonging to a particularmiRNA family and the identification
of small RNAs that are underrepresented.
One of the mechanisms behind the progression of tumors
is acquired resistance to apoptosis (Hanahan and Weinberg
2011). In particular, anoikis has been shown to play an im-
portant role during tumorigenesis (Chiarugi and Gian-
noni 2008). The regulation of apoptotic cell signalling by
miRNAs is still not fully understood despite considerable re-
search during recent years (Lima et al. 2011). Several miRNAs
have been shown to repress anoikis by targeting different
genes (Gramantieri et al. 2009; Penna et al. 2011). In this
work, we have identified caspase 3 as a main target down-reg-
ulated by miR-30b/c conferring an anoikis-resistance pheno-
type in immortalized epithelial cells. A single miRNA can
block the expression of many target mRNAs. However, the
anoikis-resistant phenotype observed with miR-30b/c over-
expression could be mimicked using a specific CASP3
shRNA and overcome by CASP3 expression, suggesting
that cell death inhibition by miR-30b/c was mainly mediated
through down-regulation of pro-CASP3 levels. In fact, previ-
ous reports have demonstrated that down-regulation of pro-
CASP3 expression leads to reduced apoptosis induced by dif-
ferent stimuli (Kugler et al. 2005; Ovcharenko et al. 2007).
Other cell death processes depending on caspase 3 were
controlled by miR-30b/c, including TRAIL-induced cell
death, which was partially abolished in immortalized epithe-
lial MCF10A cells overexpressing these miRNAs. In agree-
ment with this result, a subset of miRNAs that targets
pro-CASP3 in other cellular and genetic backgrounds, such
as miR-155, miR-Let-7a, miR-378, and more notably, miR-
30b/c/d, enhanced cell viability and suppressed apoptosis in
different physiological contexts, suggesting that their deregu-
lationmay lead, in the case of some of them, to tumorigenesis
(Tsang and Kwok 2008; Fang et al. 2011; Wang et al. 2011; Li
et al. 2012a; Quintavalle et al. 2013). Strikingly, Kaposi’s sar-
coma herpesvirus miR-K12-1, -3, and -43p miRNAs targeted
endogenous caspase 3. This resulted in decreased apoptosis
activity in different cell types, which could contribute to the
malignant phenotype triggered by KSHV infection (Suffert
et al. 2011). These results point to the possible role of miR-
30b/c as oncomirs through blocking caspase 3 expression.
In this regard, the overexpression of miR-30b/c led to a delay
in acini clearance linked to decreased CASP3 activation when
a three-dimensional Matrigel-induced acinar morphogenesis
assay system was used. This model resembles important his-
topathological features observed in epithelial cancers in
vivo (Debnath and Brugge 2005). Interestingly, miR-30c has
been reported as highly expressed in different types of solid
cancers such as prostate, colon, and pancreas (Volinia et al.
2010), and the overexpression of miR-30b has been related
to high metastatic potential of melanoma cells (Gaziel-
Sovran et al. 2011) and to medulloblastoma (Lu et al. 2009).
Recently,miR-30b/c have been described as important factors
in the resistance to gefinitib by targeting BIM in lung cancers
(Garofalo et al. 2011). However, we could not observe a
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depletion of BIM in the immortalized cell line RPE-1.
Probably, this could be explained by differences in the genetic
backgrounds of these cell types. On the other hand, lack of ex-
pression of caspase 3 has been described in breast cancer
(Devarajan et al. 2002) and in human prostatic tumors.
Remarkably, a significant loss of CASP3 protein, but not
mRNA levels, has been reported in human prostatic tumors
(Winter et al. 2001), suggesting a post-transcriptional control
of caspase 3 expression as it has been described in this
work, mediated by miR-30b/c. Altogether, these findings in-
dicate that the overexpression of miR-30b/c can represent a
potential step during the loss of apoptotic control during
tumorigenesis.
Furthermore, high levels of miR-30b/c could also play an
important role in resistance to death ligand-induced and
drug-induced apoptosis in cancer cells, as described here
for human mammary epithelial cells and in other cell types
in which caspase 3 expression is inhibited by these and other
miRNAs (Suffert et al. 2011; Wang et al. 2011; Quintavalle
et al. 2013), confirming the network miR-30b/c-caspase 3
as a broad contributing factor for tumorigenesis. However,
it cannot be ruled out that other effects arising from the over-
expression of miR-30b/c could affect tumor progression.
In summary, our data highlight the power of our system to
generate novel small RNA expression libraries that can be
used to perform large-scale screens for gain-of-function phe-
notypes in any given biological phenomenon. As a proof of
principle, and as an example of the identification of novel
functions for known miRNAs, we isolated two miRNAs
that confer cellular resistance to anoikis. Furthermore, the
unbiased nature of our technology provides the possibility
to discover previously undescribed miRNAs and other types
of small RNAs functioning as miRNA or siRNA with regula-
tory functions, which constitutes an important breakthrough
when compared to current approaches. We believe that this
methodology will lead to a better understanding of the com-
plex mechanisms underlying the control of gene expression
by small noncoding RNAs.
MATERIALS AND METHODS
Cell culture
Immortalized human retinal pigment epithelial cell line hTERT
RPE-1 (Clontech) was maintained in DMEM/F12 supplemented
with 10% fetal bovine serum (FBS), 2 mM L-glutamine, and antibi-
otics (50 units/mL penicillin, 50 μ/mL streptomycin). HEK293T
transformed cell line and colorectal carcinoma HCT116 cell line
(obtained from the American Type Culture Collection) were grown
in DMEM andMcCoy’s 5A, respectively, with the same supplements
as RPE-1 cells. The human breast epithelial cell line MCF-10A was
grown in DMEM/F12 supplemented with 5% donor horse serum, 2
mM L-glutamine, 20 ng/mL epidermal growth factor (EGF), 10 μ/
mL insulin, 100 ng/mL cholera toxin/mL, and 0.5 µg/mL hydrocor-
tisone.MDA-MB-231 (clone 4175) cells were grown in high-glucose
DMEM medium with 10% fetal bovine serum.
Constructs
The pLENT-DUAL plasmid has been derived from pFIV-H1/U6-
Puro (System Biosciences) with the following modifications. The
puromycin gene was replaced by EGFP as a marker. In addition,
the modified lentiviral vector pLENT-DUAL contains two RNA po-
lymerase III terminators downstream from the transcriptional start
sites of H1 and U6 promoters and two BbvII restriction sites as a
cloning site. Processed sequences (mature miRNA based-DNA
oligonucleotides annealed to their complementary sequences) of
different small RNAs were cloned into the BbvII cloning sites
flanked by both RNA polymerase III promoters H1 and U6
(Supplemental Fig. S1). The pLuc-BS plasmid was derived from
pCDNA3.1 and contains the ORF of the luciferase gene luc2
(Photinus pyralis) obtained from the pGL4 plasmid (Promega), fol-
lowed by a multicloning site (XbaI, KpnI, BamHI, BstXI, EcoRI,
EcoRV, NotI, XhoI, and PmeI restriction sites) where binding sites
sequences for the different miRNAs or complete 3′ UTR of caspase 3
were cloned. The 3′ UTR of caspase 3 was amplified by PCR using
the primers 5′-CCGAATTCAGAAATGGTTGGTTGGTGGTT-3′
and 5′-CCCTCGAGTAATTTTAAGTTTGAATGTATATTTTG-3′,
containing EcoRI and XhoI restriction sites, respectively.
Transfections, lentivirus production,
and infections
Transfection of HCT116 cells was performed using Lipofectamine
2000 reagent (Invitrogen) following the manufacturer’s protocol.
Transfection of HEK293T cells was performed using the CalPhost
Kit (Clontech). The HIV packaging (pCMVDR8.91) and VSV-G
(pMDG) plasmids and the lentiviral vectors pHRSIN-DUAL-GFP
(also known as pHRSIN-CSGWdINotI_pUb_Em [Mazzon et al.
2009]) were kindly provided by Mary K. Collins (Windeyer
Institute, London). The full-length miR-30b/c and ORF sequence
of caspase 3 were cloned into the BamHI/NotI restriction sites of
the pHRSIN-DUAL-GFP plasmid. The lentiviral vectors pGIPZ-
30d (Gaziel-Sovran et al. 2011) and pLKO-30a (Baraniskin et al.
2012), containing miRNA-30d and miR-30a precursors, respective-
ly, and their corresponding controls were kindly provided by Eva
Hernando (New York University Medical Center) and Stephan
A. Hahn (Molecular GI-Oncology, Center of Clinical Research,
Ruhr-University, Bochum, Germany), respectively.
Fragments of 675 bp and 665 bp containing pre-miR-30b and
pre-miR-30c-1, respectively, were amplified from RPE-1 genomic
DNA using the primers 5′-CGGGATCCCCTGGGCAATATAGTG
AGACC-3′ and 5′-CGGCGGCCGCATTGAGTAACAAATTTAAA
GG-3′ for pre-miR-30b and 5′-CGGGATCCGATGGGGTCAAT
ACCAGCTTG-3′ and 5′-CGGCGGCCGCGGTTAATGGGAAACA
GGGCTTTTCC-3′ for pre-miR-30c-1. Caspase 3 ORF sequence
was amplified using the primers 5′-GCGGATCCATGGAGAACAC
TGAAAACTCAG-3′ and 5′-CACGCGGCCGCTTAGTGATAAAA
ATAGAGTTC-3′. Insertion and orientation of DNA fragments
were confirmed by restriction enzyme digestions and sequencing.
For the production of lentivirus, 3 × 106 293T cells were seeded
onto a 10-cm Petri dish and transfected with Lipofectamine 2000
(Invitrogen) using 13.5 µg of the transfer vector pHRSIN carrying
caspase 3 ORF, miR-30b, or miR-30c-1, pGIPZ-30d, pLKO-30a,
or their corresponding controls, 9 µg of pCMVDR8.91, and 4.5 µg
pf pMDG. Lentiviruses were harvested 48 h post-transfection, passed
through a 0.45-µm filter, and concentrated by ultracentrifugation at
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100,000g for 90 min. Virus particles were resuspended in serum-free
DMEM-F12 (Invitrogen) and stored at−80°C. Lentiviral particle ti-
ters were determined by flow cytometry in RPE-1 and MCF10A in-
fected cells yielding 10 mL of 0.1–1 × 106 infection units per mL of
nonconcentrated supernatant from one 10-cm culture dish (pLKO,
pSIN-DUAL, pGIPZ). For infection with the lentiviral stock, RPE-1
or MCF10A cells were seeded at 8 × 104 cells in a six-well plate 24 h
prior to infection, then lentiviral particles (MOI = 4 for miRNAs ex-
pression and MOI = 2 for CASP3 expression) were added, and the
culture medium was replaced 24 h after infection. In the case of
MCF10A cells, 8 µg/mL polybrene were added. Production of FIV
pseudoviral particles (pLENT-DUAL) was performed using the
pFIV Packaging kit (System Biosciences) following the manufactur-
er’s protocol with minor modifications. The yield of recombinant
dual promoter lentiviral particles was 10 mL of 5–9 × 104 infection
units per mL of nonconcentrated supernatant from one 10-cm cul-
ture dish, resulting in titers about 10-fold lower, on average, than
other conventional lentiviruses. Transduction of cells with FIV len-
tiviruses was carried out as described above for pHRSIN-DUAL at
MOI = 2. The lentiviral DNAwas amplified by PCR using the prim-
ers H1: 5′-AATGTCTTTGGATTTGGGAATCTTATA-3′ and U6:
5′-AAAGTAATAATTTCTTGGGTAGTTTGC-3′. Lentiviruses for
shRNA interference of CASP3 mRNA were purchased from
Sigma-Aldrich. RPE-1 cells were infected at MOI = 4 and grown
for 12 d in puromycin at 4 µg/mL. Experiments were carried out
uniquely with puromycin-resistant RPE-1 cells.
Library construction
Total RNA from MDA-MB-231 human breast cancer cells was ex-
tracted by using TRIZOL Reagent (Invitrogen) according to the
manufacturer’s instruction. RNAs of 19 to 29 nt in length were
size-selected on a 15% denaturing polyacrylamide gel, eluted, and
ethanol-precipitated in siliconized tubes, with glycogen as carrier.
Gel-purified RNAwas first dephosphorylated to prevent circulariza-
tion and incubated with 5 µM 3′-adapter oligonucleotide (5′-
puuuuuuGTCTTCACTGAGCGGGCATA/3ddC/-3′; p, phosphate;
ddC, Dideoxycytidine; lowercase, RNA; uppercase, DNA) with a
blocked 3′ terminus to prevent the participation in the ligation reac-
tion (50 mMTris-HCl, pH 7.8, 10 mMMg Cl2, 10 mMDTT, 1 mM
ATP, 15% DMSO, 1 unit/µL T4 RNA ligase). The ligation products
of 46 to 56 nt were purified on a 15% denaturing polyacrylamide gel.
The eluted product was phosphorylated and added to a secondary
T4 RNA ligase reaction, similar to the first one except that 5 µM
5′-adapter oligonucleotide (5′-CGGCTCAACTCTCTGGAAGAC
TCaaag-3′; lowercase, RNA; uppercase, DNA) replaced the
3′-adapter oligonucleotide. The new ligation products were gel-
purified and reverse transcribed into cDNAs in a standard 30-µL re-
verse transcription reaction (SuperScript III; Invitrogen) with the
biotinylated RT primer (5′-/5Bio/GTATGCCCGCTCAGTGAA).
The cDNAwas amplified, using 10 µL from the reverse transcription
reaction as a template, the RT primer, and a biotynilated oligonucle-
otide within the 5′-adapter (5′-/5Bio/CGGCTCAACTCTCTGG
AA-3′) following this PCR protocol: 2 min at 94°C, 20 cycles of
45 sec at 94°C, 30 sec at 50°C, and 30 sec at 72°C, and a final step
of 7 min at 72°C. PCR products were gel-purified, ethanol-precipi-
tated, and digested with BbvII restriction enzyme. Digested products
were incubated with streptavidin-coupled Dynabeads (Invitrogen),
and the supernatant, containing the internal fragments, was etha-
nol-precipitated. The small cDNA fragments were directionally
cloned into the BbvII-digested pLENT-DUAL lentiviral vector. E.
coli cells were electroporated and more than 8 × 105 independent
colonies were pooled to comprise the library.
RNA and DNA samples for deep-sequencing
libraries
Fifty nanograms of size-selected miRNA (19–29 nt, using acrylam-
ide gel separation) was used for miRNA library construction with
the Ion Total RNA-Seq Kit v2 following the Ion Total RNA-Seq
Kit v2 for Small RNA Libraries protocol. One hundred nanograms
of amplicons (10 cycles of amplification using the primers H1: 5′-
AATGTCTTTGGATTTGGGAATCTTATA-3′ and U6: 5′-AAAG
TAATAATTTCTTGGGTAGTTTGC-3′) from the pLENT-DUAL li-
brary with an average length of 250 nt was used for PCR products
library construction with the Ion Xpress Plus Fragment Library
kit following the protocol for >400-nt PCR products detailed on
the Ion Xpress Plus gDNA and Amplicon Library. Library concen-
trations were estimated with Q-PCR with the Ion Library
Quantification kit (Life Technologies) prior to clonal amplification.
Emulsion PCR and sequencing
The emulsion PCR was carried out applying the Ion Xpress
Template kit V2.0 (Life Technologies) as described in the appropri-
ate user guide provided by the manufacturer. Quality and quantity
of the enriched spheres were checked on a Qubit 2.0 instrument us-
ing the Qubit assay (Life Technologies) as described in the appendix
of the Ion Xpress Template Kit User Guide. Sequencing of the librar-
ies was carried out on the Ion Torrent Personal Genome Machine
(PGM) system (Lifesequencing S.L.) using the Ion Sequencing 200
kit following the corresponding protocol. In brief, the chip was
washed, and the spheres were loaded twice onto a 318 chip (Life
Technologies); each loadingwas followed by four rounds of centrifu-
gation at maximum speed for 1 min (Mini Star; VWR International
GmbH), and the complete samplewas loaded. For every sample a sep-
arate 318 chip was used.
Bioinformatics
Analysis of the sequencing data was performed by miR-Intess small
RNA pipeline (InteRNA Genomics B.V.) (Berezikov et al. 2010).
Reads were preprocessed to trim the adapter sequences and mapped
against the human genome assembly GRCh37. Annotations of the
mapped loci were retrieved from Ensemble database (v. 69) and
from miRBase (v. 19), and aligned reads were classified according
to these annotations. Prediction of novel miRNA candidates was
performed by miR-Intess as described previously (Berezikov et al.
2010).
RNase protection assay
The expression of processed miRNAs from pLENT-DUAL was an-
alyzed by RNase protection assay (RPA). HEK293T cells were seeded
in six-well plates at 50% confluence the day before transfection.
Forty hours after transfection, RNA was collected and enriched in
small RNA using the mirVana miRNA Isolation kit (Ambion).
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The mirVana miRNA probe construction kit (Ambion) was used to
synthesize 32P-labeled miR-21, miR-19a, miR-15a, miR-30a, miR-
30b, miR-30c, and miR-30d sense (guide strand) and antisense
(complementary strand) probes. Primers to make the RPA probes
are listed in the Supplemental Material. Probe hybridization and
RNase protection were carried out using themirVanamiRNA detec-
tion kit (Ambion) according to the manufacturer’s instructions.
After hybridization and RNase treatment, the protected RNAs
were resolved on a 15% denaturing urea polyacrylamide gel and vi-
sualized using phosphoimaging and autoradiography. RNAmarkers
were γ-32P-end-labeled Decade RNA markers (Ambion) prepared
according to the manufacturer’s instructions.
Luciferase assays
Cells were harvested 40 h post-transfection and luciferase activity
was measured using a luciferase assay kit (Promega) according to
the manufacturer’s protocol. Renilla activity was used for normali-
zation control.
Soft-agar anoikis assay
Cells were plated at a density of 105 cells per 100-mm plate with a
bottom layer of 3% agarose and a top layer of 0.5% agarose. The
functional screening was carried out plating 1.2 × 106 and 2 × 105
cells infected with lentiviral library and pLENT-DUAL (empty) as
a control, respectively. Cells were grown for 19 d at 37°C in 5%
CO2, and clones were picked up under a dissecting microscope
and transferred to adhesive plates to allow their expansion.
Seventeen anoikis-resistant clones were finally obtained from cells
infected with the library and one clone from control cells that was
unable to grow on adhesive plates.
Short-term cell death assays
Anoikis was induced in vitro by transferring serum-deprived RPE-1
cells, to plates treated with polyHEMA (to prevent cellular-matrix
adhesion) in the presence of 2% methylcellulose (to inhibit cell-
cell interactions) and serum-free medium for an additional 24 h.
For TRAIL-mediated cell death experiments, MCF10A cells were
treated with this apoptosis inducer at 500 ng/mL for 7 h. Soluble hu-
man His-tagged recombinant TRAIL (residues 95–281) was pro-
duced as previously described (Yerbes et al. 2011).
Immunoblotting
Cell lysates were prepared by lysing cells in RIPA buffer (50 mM
Tris-Cl, pH 7.4, 150 mMNaCl, 1% NP40, 0.25% Na-deoxycholate)
containing a complete cocktail of protease inhibitors (Roche Dia-
gnostics) plus 1 mM PMSF and resolved on SDS-PAGE.
Immunoblotting was performed on nitrocellulose membrane ac-
cording to the manufacturer’s instructions. Commercially available
antibodies to full-length and cleaved CASP3 (Cell Signaling), β-actin
(Sigma-Aldrich), p53 (Santa Cruz Technology), and BIM-EL
(Calbiochem) were used as recommended by the manufacturers.
Signals were detected by using the Enhanced Chemilumiescence
Reagent ECL kit (GE Healthcare). Protein levels were quantified us-
ing LabScan and ImageQuant TL software (GE Healthcare).
Quantitative RT-PCR
Real time PCR experiments were carried out using 1 µL of cDNAs
generated from 1 µg of total RNA using the Qiagen OneStep RT-
PCR kit (Qiagen). The Quantimir RT Small RNA Kit (System
Biosciences) was used for small RNA quantification following the in-
structions of themanufacturer. Expression ofCASP3,HPRT, mature
miR-30b/c, miR-16, and U6 snRNA (System Biosciences) were de-
termined by using the LightCycler-FastStart DNA SYBR Green I
Kit (Roche) and the ABI PRISM 7500 instrument (Applied
Biosystems). The PCR cycling profile consisted of incubation at
50°C for 2 min, followed by a denaturing step at 95°C for 10 min,
and 40 cycles at 95°C for 15 sec, and 60°C for 1 min for CASP3
andHPRT and at 63°C for 1min formiRNAs. The following primers
were used: CASP3: forward, 5′-CAGAGGGATCGTTGTAGAA-3′
and reverse, 5′-GTATGCATACAAGAAGTCGGC-3′; HPRT: for-
ward, 5′-GGACTAATTATGGACAGGACTG-3′ and reverse, 5′-
TCCAGCAGGTCAGCAAAGAA-3′. For miR-30b/c and miR-16,
the forward primers corresponded to the mature sequence of these
miRNAs, and the 3′ universal reverse primer was provided with
the Quantimir RT Small RNA Kit. Alternatively, for quantitative
real-time PCR of miRNA-30a and miRNA-30d, 15 ng of total
RNA was reverse-transcribed in a 10-μL total reaction using specific
stem–loop RT primers (Applied Biosystems), and 2.5 μL of cDNA
was subjected to a TaqMan miRNA assay (Applied Biosystems)
in a 20-μL total reaction using primers and a probe specific for
miR-30a or miR-30d, according to the manufacturer’s protocol.
Expression values were calculated using a comparative Ct method.
miR-324 and U6-snRNA (RNU6B) were used as endogenous
controls.
Flow cytometry
For flow cytometry analysis, floating and adherent cells were washed
in phosphate-buffered saline (PBS), fixed in 70% ethanol, and
stained with propidium iodide (50 µg/mL). EGFP-expressing cells
were analyzed without previous fixation. Cells were analyzed by us-
ing a FACScalibur (Becton Dickinson Immunocytometry Systems).
Morphogenesis assay and immunofluorescence
Assays were performed as previously described (Yerbes et al. 2011).
Briefly, MCF-10A cells were resuspended in assay medium (DMEM/
F12 supplemented with 2% donor horse serum, 10 μg of insulin/mL,
100 ng of cholera toxin/mL, 0.5 μg of hydrocortisone/mL, and 5 ng
of EGF/mL) 4 d after infection with different lentiviruses. Eight-well
RS glass slides (BD Falcon) were coated with 40 μL of Matrigel per
well. Five thousand cells per well were plated in assay medium con-
taining a final concentration of 2% Matrigel and replaced every 4
d. For the immunofluorescence experiments, acini were fixed in
4% formalin for 25 min at room temperature. Fixed structures
were washed with PBS-glycine (130 mM NaCl, 7 mM Na2HPO4,
100 mM glycine, pH 7.4) three times for 15 min each time. The
structures were then blocked in IF buffer (130 mM NaCl, 7 mM
Na2HPO4, 3.5 mM NaH2PO4, 7.7 mM NaN3, 0.1% bovine serum
albumin, 0.2% Triton X-100, 0.05% Tween-20) plus 10% goat se-
rum for 1 to 2 h, followed by 2% blocking buffer (i.e., IF buffer con-
taining 10% goat serum and 20 μg of goat anti-mouse F(ab)2/mL)
for 40 min. Primary antibodies against cleaved CASP3 (Cell
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Signaling) and α6-Integrin (Chemicon) were diluted in 2% blocking
buffer, followed by incubation overnight at 4°C. Structures were
washed three times in IF buffer for 15 min each. Anti-mouse or
anti-rabbit secondary antibodies coupled with Alexa Fluor dyes
(Molecular Probes) were diluted in IF buffer containing 10% goat
serum, followed by incubation for 60 min. After a wash with IF buff-
er as described above, structures were incubated with 0.5 ng of DAPI
(4′,6-diamidino-2-phenylindole)/mL (Sigma) before being mount-
ed with the anti-fade agent Prolong Gold (Molecular Probes).
Confocal analysis was performed in a Leica TCS-SP5 laser micro-
scope. Active CASP3 was determined in GFP-positive acini.
SUPPLEMENTAL MATERIAL
Supplemental material is available for this article.
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